KLA CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data KLA CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	3,480	4,037	4,569	5,806	6,919	9,212	10,496	9,812	12,156	13,579
Cost of revenue	1,286	1,446	1,869	2,450	2,772	3,592	4,218	3,928	4,752	5,255
Gross profit	2,194	2,591	2,700	3,357	4,147	5,619	6,278	5,884	7,404	8,324
Research and development	527	609	711	864	928	1,105	1,297	1,279	1,360	1,532
Selling, general and administrative	388	442	599	734	730	860	986	970	1,030	1,132
Interest expense	122	114	125	160	157	160	297	311	302	284
Interest income	23.3	36.9	40.4	21.6	8.93	8.7	74.1	161	180	177
Other non-operating income	-6	30.5	31.5	-2.68	29.3	-4.61	105	155	171	230
Pre-tax income	1,173	1,456	1,296	1,317	2,360	3,489	3,789	3,190	4,644	5,606
Income tax	247	654	121	102	283	167	402	428	583	775
Net income to minority interests	0	0	-0.6	-1.76	-0.94	0.25	0.07	0	0
Net income	926	802	1,176	1,217	2,078	3,322	3,387	2,762	4,062	4,831
EPS, basic	0.59	0.51	0.75	0.78	1.35	2.21	2.43	2.04	3.05	3.68
EPS, diluted	0.59	0.51	0.75	0.77	1.34	2.19	2.42	2.03	3.04	3.66
Shares, basic (weighted)	1,563	1,562	1,559	1,566	1,539	1,503	1,393	1,353	1,330	1,312
Shares, diluted (weighted)	1,573	1,572	1,568	1,578	1,553	1,514	1,401	1,362	1,338	1,320
Dividend per share	0.21	0.25	0.30	0.33	0.36	0.42	0.52	0.57	0.68	0.80

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	1,153	1,404	1,016	1,234	1,435	1,585	1,928	1,977	2,079	1,650
Short-term investments	1,864	1,476	723	746
Receivables	571	652	990	1,107	1,305	1,812	1,753	1,833	2,264	2,889
Inventory	733	932	1,263	1,311	1,575	2,147	2,877	3,035	3,212	3,649
Other current assets	71.2	85.2	323	325	321	502	499	659	728	942
Total current assets	4,392	4,549	4,315	4,724	5,696	7,169	8,372	10,031	10,699	12,382
Property, plant and equipment	284	286	449	520	663	850	1,032	1,110	1,253	1,381
Lease right-of-use assets				101	103	126	209	232	270	335
Goodwill	350	355	2,212	2,045	2,011	2,320	2,279	2,016	1,792	1,789
Intangible assets	19	19.3	1,561	1,391	1,185	1,194	935	669	445	256
Other non-current assets	196	236	266	363	445	485	637	693	774	1,107
Total assets	5,532	5,639	9,009	9,280	10,271	12,597	14,072	15,434	16,068	17,952
Accounts payable	147	169	202	264	342	443	371	359	459	624
Accrued liabilities	173	174	226	251	305	352	371	372	419	491
Deferred revenue										1,537
Short-term debt	250	0	250	0	20	0	0	750	0
Total current liabilities	1,293	1,214	1,768	1,700	2,103	2,871	3,743	4,661	4,086	4,305
Long-term debt	2,680	2,237	3,173	3,470
Lease liabilities				70.9	70.7	81.4	138	153	159	211
Other non-current liabilities	172	493	588	672	631	883	813	743	610	698
Total liabilities	4,206	4,018	6,331	6,599	6,895	11,198	11,153	12,065	11,375	11,602
Total debt	2,930	2,237	3,423	3,470	3,423	6,661	5,891	5,880	5,884	5,887
Paid-in capital	529	618	2,017	2,090	2,176	1,062	2,108	2,280	2,512	2,699
Retained earnings	848	1,056	715	655	1,277	367	848	1,137	2,179	3,684
Other comprehensive income	-51.3	-53.9	-73	-79.8	-75.6	-27.5	-36.3	-49.1	1.2	-34.5
Shareholders' equity	1,326	1,621	2,659	2,665	3,378	1,401	2,920	3,368	4,692	6,350
Minority interests		0	18.6	15.6	-1.91	-2.26	0
Total equity	1,326	1,621	2,678	2,681	3,376	1,399	2,920	3,368	4,692	6,350
Total liabilities and equity	5,532	5,639	9,009	9,280	10,271	12,597	14,072	15,434	16,068	17,952
Shares outstanding	1,567	1,559	1,593	1,553	1,526	1,417	1,366	134	1,320	1,307

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	926	802	1,175	1,215	2,077	3,322	3,387	2,762	4,062	4,831
Depreciation and amortization	57.8	62.7	233	348	333	363	415	402	394	394
Stock-based compensation	50.9	62.8	94.2	111	112	127	171	213	265	310
Deferred income tax	3.47	101	-26.2	-93.3	-45.6	-354	-355	-139	-245	87
Change in receivables	39.8	-76	-354	-117	-198	-506	58.5	-79.7	-431	-625
Change in inventory	-46.5	-180	-59.6	-74.8	-270	-567	-749	-164	-155	-466
Change in payables	40	21.8	-21.6	61.1	79.4	102	-145	25	33.8	172
Cash from operations	1,080	1,229	1,153	1,779	2,185	3,313	3,670	3,309	4,082	4,143
Capital expenditures	-38.6	-66.9	-130	-153	-232	-307	-342	-277	-335	-376
Acquisitions	-28.6	-17.4	-1,818	-90.1	0	-479	-27.1	-3.68	0	0
Purchases of investments	-3.43	-3.38	-0.63	-798	-1,019	-988	-1,442	-2,757	-2,773	-3,711
Sales and maturities of investments	699	608	589	627	582	761	1,134	1,460	2,456
Cash from investing	-561	292	-1,181	-259	-500	-876	-483	-1,477	-202	-1,190
Debt repaid	-130	-946	-902	-1,171	-70	-620	-1,087	0	-750	0
Stock issued	45.4	61.4	64.8	75.6	86.1	113	125	145	152	169
Share buybacks	-25	-203	-1,095	-829	-939	-3,968	-1,312	-1,736	-2,150	-2,290
Dividends paid	-344	-402	-472	-522	-559	-639	-733	-773	-905	-1,058
Cash from financing	-473	-1,270	-360	-1,300	-1,498	-2,257	-2,830	-1,776	-3,786	-3,386
Exchange rate effect	-1.41	0.7	-0.03	-1.93	13.5	-28.9	-14	-6.31	8.04	3.56
Net change in cash	44.6	251	-388	218	200	150	343	49.3	102	-429
Free cash flow	1,041	1,162	1,022	1,626	1,953	3,005	3,328	3,031	3,747	3,767
Interest paid	120	114	107	153	154	155	224	277	293	283
Income taxes paid	234	253	180	205	326	465	495	831	887	781

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $187.92 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	61.3%	Gross profit / revenue.
Pre-tax margin	41.3%	Pre-tax income / revenue.
Net margin	35.6%	Net income / revenue.
FCF margin	27.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	30.5%	Cash from operations / revenue.
Effective tax rate	13.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	87.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	28.4%	Net income / average total assets.
R&D / revenue	11.3%	Research and development expense / revenue.
SG&A / revenue	8.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	2.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.8%	Capital expenditures / revenue.
D&A / revenue	2.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	11.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	9.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	14.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	12.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	9.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	15.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	18.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	12.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	18.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	20.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	14.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	22.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	1.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	4.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	13.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	0.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	4.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	14.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	18.5%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	15.4%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	17.3%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	35.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	29.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	13.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	11.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	8.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	11.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-3.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.88x	Current assets / current liabilities.
Quick ratio	1.05x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.38x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.93x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	32.8%	Total debt / total assets.
Liabilities / assets	64.6%	Total liabilities / total assets.
Net debt	$4.24B	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$8.08B	Current assets - current liabilities.
Goodwill and intangibles / assets	11.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$4.31B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.80x	Revenue / average total assets.
Fixed asset turnover	10.3x	Revenue / average property, plant and equipment.
Inventory turnover	1.53x	Cost of revenue / average inventory.
Days inventory	238 days	365 x average inventory / cost of revenue.
Receivables turnover	5.27x	Revenue / average receivables.
Days sales outstanding	69 days	365 x average receivables / revenue.
Days payables	38 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	270 days	Days inventory + days sales outstanding - days payables.
FCF conversion	78.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	9.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.66	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$3.68	Net income per basic share, as reported (split-adjusted).
Revenue per share	$10.29	Revenue / diluted weighted shares.
FCF per share	$2.85	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.14	Cash from operations / diluted weighted shares.
Book value per share	$4.86	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$3.29	Tangible book value / shares outstanding.
Cash per share	$1.26	(Cash + short-term investments) / shares outstanding.
Dividend per share	$0.80	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	21.9%	Dividends paid / net income, when net income is positive.
Dividends / FCF	28.1%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	60.8%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$245.53B	Share price x shares outstanding.
Enterprise value	$249.76B	Market cap + total debt - cash - short-term investments.
P/E	50.8x	Market cap / net income. Only when net income is positive.
P/S	18.1x	Market cap / revenue.
P/B	38.7x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	57.0x	Market cap / tangible book value, when positive.
P/FCF	65.2x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	59.3x	Market cap / cash from operations, when positive.
EV/Sales	18.4x	Enterprise value / revenue.
EV/FCF	66.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.5%	Free cash flow / market cap.
Earnings yield	2.0%	Net income / market cap (the inverse of P/E).
Dividend yield	0.4%	Dividends paid over the period / market cap.
Shareholder yield	1.4%	(Dividends paid + share buybacks) / market cap.
PEG	3.43x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was KLA CORP's revenue in fiscal 2026?

KLA CORP reported revenue of $13.58B for fiscal 2026, 11.7% higher than the year before.

Was KLA CORP profitable in fiscal 2026?

Yes. Net income was $4.83B, a net margin of 35.6%.

How much free cash flow did KLA CORP generate in fiscal 2026?

Cash from operations of $4.14B minus capital expenditures of $375.9M left free cash flow of $3.77B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to KLA CORP